Ulodesine succinate anhydrous
Product Specifications
CAS Number
1246200-39-4
Bioactivity
Ulodesine (also known as BCX4208) is a purine nucleotide phosphorylase (PNP) inhibitor being developed by Biocryst for the treatment of gout. Intended as a once-daily oral therapy, it functions by impacting the purine metabolic pathway upstream of xanthine oxidase to decrease serum uric acid (sUA) levels. Its half-maximal inhibitory concentration (IC (50) ) for PNP is 0.5 nM. Currently, BCX-4208 is in early clinical trials to evaluate its potential benefits in treating psoriasis and gout.
Smiles
OC(CCC(O)=O)=O.O=C(N=CN1)C2=C1C(CN3C[C@@H]([C@H](C3)O)CO)=CN2.O=C(N=CN4)C5=C4C(CN6C[C@@H]([C@H](C6)O)CO)=CN5
Molecular Formula
C12H16N4O3 1/2C4H6O4
Molecular Weight
323.325
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
15977121 3x 1.0µg DNA
CFHR5 CRISPRa sgRNA lentivector (set of three targets)(Human)
Sign In for Pricing
View Details 
G0198 96 Tests
Potassium voltage-gated channel subfamily A member 5 (KCNA5) Mouse ELISA Kit
Sign In for Pricing
View Details MBS6427871-01 0.1 mL
MYCBP (C-myc Binding Protein, Associate of Myc-1, AMY-1) (AP)
Sign In for Pricing
View Details